Lipofibromatosis: Difference between revisions
Content deleted Content added
←Created page with '{{Infobox medical condition (new) | name = Lipofibromatosis | synonyms = | image = | caption = | pronounce = | field = Dermatology, General surgery | symptoms = | complications = | onset = Very rapid | duration = Often regresses spontaneously within weeks of diagnosis | types = | causes = | risks = | diagnosis = | differential...' |
(No difference)
|
Revision as of 15:32, 17 August 2021
| Lipofibromatosis | |
|---|---|
| Specialty | Dermatology, General surgery |
| Usual onset | Very rapid |
| Duration | Often regresses spontaneously within weeks of diagnosis |
| Treatment | symptomatic therapy, watchful waiting, surgical resection |
| Prognosis | Excellent |
| Frequency | Extremely rare |
Lipofibromatosis is a rare soft tissue tumor which was first clearly described in 2000 by Fetsch et al.[1] The disorder had been considered a type of or closely similar to infantile fibromatosis,[2] aponerotic fibroma (also termed calcifying aponeurotic fibroma),[3] and EWSRI-SMAD3-rearranged fibroblastic tumor (also termed EWSR1-SMAD3-positive fibroblastic tumor).[4]
References
- ^ Fetsch JF, Miettinen M, Laskin WB, Michal M, Enzinger FM (November 2000). "A clinicopathologic study of 45 pediatric soft tissue tumors with an admixture of adipose tissue and fibroblastic elements, and a proposal for classification as lipofibromatosis". The American Journal of Surgical Pathology. 24 (11): 1491–500. doi:10.1097/00000478-200011000-00004. PMID 11075850.
- ^ Al-Ibraheemi A, Folpe AL, Perez-Atayde AR, Perry K, Hofvander J, Arbajian E, Magnusson L, Nilsson J, Mertens F (March 2019). "Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases". Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. 32 (3): 423–434. doi:10.1038/s41379-018-0150-3. PMID 30310176.
- ^ John I, Fritchie KJ (January 2020). "What is new in pericytomatous, myoid, and myofibroblastic tumors?". Virchows Archiv : an International Journal of Pathology. 476 (1): 57–64. doi:10.1007/s00428-019-02700-y. PMID 31705190.
- ^ Parham DM (2018). "Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing". F1000Research. 7. doi:10.12688/f1000research.16236.1. PMC 6305242. PMID 30613391.
{{cite journal}}: CS1 maint: unflagged free DOI (link)